ERBB2 and neoplasm: For instance, Shah et al. demonstrated the capabilities of non–invasive molecular imaging of apoptosis, glucose metabolism, and cellular proliferation to correlate to tumor regression in trastuzumab–treated HER2+ xenografts, specifically apoptosis and proliferation [19].